Skip to content

Certification Documentation


MIPS Accelerator Certification

The Alpha II MIPS Accelerator 6 Modular EHR, SLI Compliance Certificate # (cert. date January 17, 2022), meets ONC 2015 certified EHR requirements for ambulatory settings for all EP electronic reporting measures. MIPS Accelerator by itself does not provide a user interface, but is the certified service to calculate and submit Quality Payment Program reporting on a client's behalf. Access to certification criteria C1 - C3 requires the purchase of the add-on QM Accelerator product. Subscription and implementation fees will apply. There are no other types of costs associated with this service.
This Health IT Module is 2015 Edition compliant and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services. ONC Certified HIT® is a registered trademark of HHS.
Certification Criteria
  • 170.315 (c)(1): Clinical Quality Measures - Record and Export
  • 170.315 (c)(2): Clinical Quality Measures - Import and Calculate
  • 170.315 (c)(3): Clinical Quality Measures - Report (Cures Update)
  • 170.315 (d)(1): Authentication, Access Control, Authorization
  • 170.315 (d)(2): Auditable Events and Tamper-Resistance (Cures Update)
  • 170.315 (d)(3): Audit Report(s) (Cures Update)
  • 170.315 (d)(5): Automatic Access Time-out
  • 170.315 (d)(12): Encrypt Authentication Credentials (Cures Update)
  • 170.315 (d)(13): Multi-Factor Authentication (Cures Update)
  • 170.315 (g)(4): Quality Management System
  • 170.315 (g)(5): Accessibility-Centered Design

View details

Clinical Quality Measures
  • CMS2: Preventive Care and Screening: Screening for Depression and Follow-Up Plan
  • CMS22: Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented
  • CMS50: Closing the Referral Loop: Receipt of Specialist Report
  • CMS56: Functional Status Assessment for Total Hip Replacement
  • CMS68: Documentation of Current Medications in the Medical Record
  • CMS69: Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan
  • CMS74: Primary Caries Prevention Intervention as Offered by Primary Care Providers, including Dentists
  • CMS75: Children Who Have Dental Decay or Cavities
  • CMS90: Functional Status Assessments for Congestive Heart Failure
  • CMS117: Childhood Immunization Status
  • CMS122: Diabetes: Hemoglobin A1c (HbA1c) Poor Control (> 9%)
  • CMS124: Cervical Cancer Screening
  • CMS125: Breast Cancer Screening
  • CMS127: Pneumococcal Vaccination Status for Older Adults
  • CMS128: Anti-depressant Medication Management
  • CMS129: Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
  • CMS130: Colorectal Cancer Screening
  • CMS131: Diabetes: Eye Exam
  • CMS133: Cataracts: 20/40 or Better Visual Acuity within 90 Days Following Cataract Surgery
  • CMS135: Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)
  • CMS136: Follow-Up Care for Children Prescribed ADHD Medication (ADD)
  • CMS137: Initiation and Engagement of Alcohol and Other Drug Dependence Treatment
  • CMS138: Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
  • CMS139: Falls: Screening for Future Fall Risk
  • CMS142: Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care
  • CMS143: Primary Open-Angle Glaucoma (POAG): Optic Nerve Evaluation
  • CMS144: Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)
  • CMS145: Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%)
  • CMS146: Appropriate Testing for Children with Pharyngitis
  • CMS147: Preventive Care and Screening: Influenza Immunization
  • CMS149: Dementia: Cognitive Assessment
  • CMS153: Chlamydia Screening for Women
  • CMS154: Appropriate Treatment for Children with Upper Respiratory Infection (URI)
  • CMS155: Weight Assessment and Counseling for Nutrition and Physical Activity for Children and Adolescents
  • CMS156: Use of High-Risk Medications in the Elderly
  • CMS157: Oncology: Medical and Radiation - Pain Intensity Quantified
  • CMS159: Depression Remission at Twelve Months
  • CMS161: Adult Major Depressive Disorder (MDD): Suicide Risk Assessment
  • CMS165: Controlling High Blood Pressure
  • CMS177: Child and Adolescent Major Depressive Disorder (MDD): Suicide Risk Assessment
  • CMS249: Appropriate Use of DXA Scans in Women Under 65 Years Who Do Not Meet the Risk Factor Profile for Osteoporotic Fracture
  • CMS347: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
  • CMS349: HIV Screening
  • CMS645: Bone density evaluation for patients with prostate cancer and receiving androgen deprivation therapy
  • CMS646: Intravesical Bacillus-Calmette-Guerin for non-muscle invasive bladder cancer
  • CMS771: International Prostate Symptom Score (IPSS) or American Urological Association-Symptom Index (AUA-SI) Change 6-12 Months After Diagnosis of Benign Prostatic Hyperplasia

View details